Aim The aim of this study was to develop two diabetes-specific preference-based measures [the Diabetes Health Profile–3 Dimension (DHP-3D) and the Diabetes Health Profile–5 Dimension (DHP-5D)] for use in the calculation of Quality Adjusted Life Years, a key outcome in… Read More ›
DHP-18
Selecting the appropriate PROM for your diabetes clinical trial
Click the image to download a free copy of the DHP User Guide Summary With the recognition of the importance of understanding the psychological impact on living with diabetes, there is now a range of diabetes specific patient re- ported… Read More ›
Migrating from paper to eDHP
The emotional impact of diabetes effects the individual and family leading to denial, poor treatment adherence, eating problems, restrictions in daily living, fears of hypoglycemia and complications such as blindness, heart disease, sexual dysfunctioning and premature death – just to… Read More ›
Researchers issue retraction that the DHP is insensitive
Researchers at the National University of Singapore have unreservedly apologised and retracted their findings published in Quality of life Research 2013;22:1-137 titled “Audit of diabetes dependent quality of life is a more sensitive measure of health-related quality of life than… Read More ›
CRF Health, University of Oxford’s Isis Outcomes and DHP Research collaborate on DHP-18 TrialMax edition
Plymouth Meeting, PA-October 15, 2013: CRF Health collaborates with Isis Outcomes and Dr. Keith Meadows of DHP Research to launch the DHP-18 TrialMax edition. The Diabetes Health Profile is a PRO measure developed to assess diabetes-specific psychological distress and restriction… Read More ›
THE RELATIONSHIP BETWEEN THE DIABETES HEALTH PROFILE AND DIABETES SPECIFIC CLINICAL INDICATORS: A CASE FOR TAILORED THERAPEUTICS
DHP Research is pleased to announce that the following presentation in collaboration with the University of Sheffield and Isis Innovations, University of Oxford has been accepted for the ISPOR 16th Annual European Congress, 2-6 November 2013, Dublin OBJECTIVES: With the… Read More ›
Upcoming webinar: Patient Reported Outcome (PRO) Measures in Diabetes Clinical Trials
Date: Thursday, September 19 at 11 a.m. ET (1 hour) Keith Meadows, PhD, DHP Research Paul O’Donohoe, Director Health Outcomes, CRF Health Diabetes has rapidly become a global epidemic affecting more than 238 million people and is expected to increase… Read More ›
A Journey of Development – The Diabetes Health Profile
The Diabetes Health Profile (DHP) is a scientifically robust, multidimensional, diabetes-specific, patient self-report outcome measure developed to provide real-world insight into the psychological and behavioural impact of living with diabetes. The DHP assesses the impact of diabetes on everyday social… Read More ›
Investigating the minimally important difference of the Diabetes Health Profile (DHP-18) and the EQ-5D and SF-6D in a UK diabetes mellitus population
Objectives: It is important to know what patient reported outcome measure (PROM) scores relate to a meaningful change in health status across time. The aim of this study was to investigate the minimally important difference (MID) of the Diabetes Health… Read More ›
ISOQOL 20th ANNUAL CONFERENCE ABSTRACT ACCEPTED – Developing the Eating Behaviour Scale for Diabetes (EBSD): A brief screening instrument for disordered eating in diabetes
Aims: Disordered eating behaviour encompassing a range of both mild and more extreme dieting behaviour in people with diabetes is a clinical concern. The aim of this study was to develop a brief screening instrument to assess sub clinical disordered… Read More ›
